Cortrosyn (Amphastar Pharmaceuticals, Inc.)


Welcome to the PulseAid listing for the Cortrosyn drug offered from Amphastar Pharmaceuticals, Inc.. This Adrenocorticotropic Hormone [Chemical/Ingredient],Adrenocorticotropic Hormone [EPC] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view the details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: Amphastar Pharmaceuticals, Inc.
NON-PROPRIETARY NAME: Cosyntropin
SUBSTANCE NAME: COSYNTROPIN
TYPE: HUMAN PRESCRIPTION DRUG
PHARMA CLASS: Adrenocorticotropic Hormone [Chemical/Ingredient],Adrenocorticotropic Hormone [EPC]
ROUTE: INTRAMUSCULAR; INTRAVENOUS
DOSAGE FORM: INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
MARKETING CATEGORY NAME: NDA
START MARKETING DATE: 2003-08-01
END MARKETING DATE: 0000-00-00


Cortrosyn HUMAN PRESCRIPTION DRUG Details:

Item DescriptionCortrosyn from Amphastar Pharmaceuticals, Inc.
LABELER NAME: Amphastar Pharmaceuticals, Inc.
DEA SCHEDULE:
ACTIVE STRENGTH: 0.25(mg/mL)
START MARKETING DATE: 2003-08-01
END MARKETING DATE: 0000-00-00
PRODUCT ID: 0548-5900_2116f568-69bb-4ed8-92ed-bd80ee412946
PRODUCT NDC: 0548-5900
APPLICATION NUMBER: NDA016750

Other COSYNTROPIN Pharmaceutical Manufacturers / Labelers:

Manufacturer / LabelerProprietary Name
Amphastar Pharmaceuticals, Inc.Cortrosyn
General Injectables & Vaccines, IncCortrosyn
Mylan Institutional LLCCosyntropin
Sandoz IncCosyntropin